Genzyme’s Perpsective: Valuing Innovation that Benefits Innovators & the Health System
In this video, Dane Bedward, Senior Vice President, Genzyme International, participates in the panel discussion Innovation and Health Sector Transformation.
Here, Bedward discusses the importance of innovations that benefit both the innovators and the health system at large. He also stresses the importance of evaluating comparative effectiveness from the clinical perspective.
- Innovation and Health Sector Transformation: Highlights from the Full Panel Discussion
- Problems in Global Competitiveness Caused by Our Multiple-Payer Healthcare Systems
- Blue Cross Blue Shield’s Innovations in Insurance Payments: Quality vs. Complexity